Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (957)	$ 5,354
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	3,391	1,611
Share based compensation	3,489	3,217
Deferred income taxes	(81)	(389)
Bad debt expense	36	66
(Increase) decrease in operating assets and increase (decrease) in operating liabilities:
Accounts receivable	(345)	257
Inventories - finished goods	3,237	(1,567)
Prepaid income taxes	426	86
Prepaid expenses and other current assets	(3,516)	(597)
Operating lease right-of-use assets, net	394	0
Accounts payable	(5,542)	(3,520)
Accrued expenses and other current liabilities	(943)	590
Lease liabilities	(383)	0
Deferred memberships fees received	579	0
Net cash (used in) provided by operating activities	(215)	5,108
Cash flows from investing activities:
Purchase of minority interest investment in Vetster	0	(5,000)
Acquisition of PetCareRx, net of cash acquired	(35,859)	0
Purchases of property and equipment	(2,137)	(2,336)
Net cash used in investing activities	(37,996)	(7,336)
Cash flows from financing activities:
Dividends paid	(12,404)	(12,306)
Net cash used in financing activities	(12,404)	(12,306)
Net decrease in cash and cash equivalents	(50,615)	(14,534)
Cash and cash equivalents, at beginning of period	104,086	111,080
Cash and cash equivalents, at end of period	53,471	96,546
Supplemental disclosure of cash flow information:
Cash paid for income taxes	0	2,560
Dividends payable in accrued expenses	$ 1,513	$ 856